PL3377049T3 - Krystaliczne formy soli tapentadolu i sposób ich wytwarzania - Google Patents

Krystaliczne formy soli tapentadolu i sposób ich wytwarzania

Info

Publication number
PL3377049T3
PL3377049T3 PL16865892T PL16865892T PL3377049T3 PL 3377049 T3 PL3377049 T3 PL 3377049T3 PL 16865892 T PL16865892 T PL 16865892T PL 16865892 T PL16865892 T PL 16865892T PL 3377049 T3 PL3377049 T3 PL 3377049T3
Authority
PL
Poland
Prior art keywords
preparation
crystalline forms
tapentadol salts
tapentadol
salts
Prior art date
Application number
PL16865892T
Other languages
English (en)
Inventor
Srinivasan Thirumalai Rajan
Muppa Kishore Kumar
Mummadi Venkatesh
Anugu PRANEETH KUMAR
Original Assignee
Msn Laboratories Private Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58718521&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3377049(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Msn Laboratories Private Limited filed Critical Msn Laboratories Private Limited
Publication of PL3377049T3 publication Critical patent/PL3377049T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL16865892T 2015-11-17 2016-11-16 Krystaliczne formy soli tapentadolu i sposób ich wytwarzania PL3377049T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN6191CH2015 2015-11-17
PCT/IN2016/000270 WO2017085734A1 (en) 2015-11-17 2016-11-16 Crystalline forms of tapentadol salts and process for preparation thereof
EP16865892.0A EP3377049B1 (en) 2015-11-17 2016-11-16 Crystalline forms of tapentadol salts and process for preparation thereof

Publications (1)

Publication Number Publication Date
PL3377049T3 true PL3377049T3 (pl) 2021-06-28

Family

ID=58718521

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16865892T PL3377049T3 (pl) 2015-11-17 2016-11-16 Krystaliczne formy soli tapentadolu i sposób ich wytwarzania

Country Status (7)

Country Link
EP (1) EP3377049B1 (pl)
DK (1) DK3377049T3 (pl)
ES (1) ES2860907T3 (pl)
HR (1) HRP20210503T1 (pl)
HU (1) HUE054338T2 (pl)
PL (1) PL3377049T3 (pl)
WO (1) WO2017085734A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2860676T3 (es) 2010-07-23 2021-10-05 Gruenenthal Gmbh Sales o cocristales de 3- (3-dimetilamino-1-etil-2-metil-propil) -fenol
PE20240113A1 (es) 2020-11-10 2024-01-22 Gruenenthal Chemie Formas de dosificacion de liberacion sostenida de una sal de tapentadol con acido l-(+)-tartarico
DE202020005470U1 (de) 2020-11-10 2022-01-25 Grünenthal GmbH Darreichungsformen mit verlängerter Freisetzung eines Salzes von Tapentadol mit L-(+)-Weinsäure
RS63521B1 (sr) 2020-11-10 2022-09-30 Gruenenthal Gmbh Oblici doze sa produženim oslobađanjem soli tapentadola sa l-(+)-vinskom kiselinom
EP4011369A1 (en) 2020-12-14 2022-06-15 G.L. Pharma GmbH Aqueous pharmaceutical composition comprising tapentadol tartrate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
AR053304A1 (es) 2004-07-01 2007-05-02 Gruenenthal Gmbh Formas farmaceuticas orales protegidas frente al abuso con liberacion controlada de (1r,2r)-3-(3 dimetilamino-1-etil-2metil-propil)fenol y procedimiento para su produccion.
TWI496762B (zh) 2006-07-24 2015-08-21 歌林達股份有限公司 製備(1r,2r)-3-(3-二甲胺基-1-乙基-2-甲基-丙基)-酚之方法
DE102007019417A1 (de) 2007-04-23 2008-11-13 Grünenthal GmbH Tapentadol zur Schmerzbehandlung bei Arthrose
US8288592B2 (en) 2009-09-22 2012-10-16 Actavis Group Ptc Ehf Solid state forms of tapentadol salts
ES2860676T3 (es) 2010-07-23 2021-10-05 Gruenenthal Gmbh Sales o cocristales de 3- (3-dimetilamino-1-etil-2-metil-propil) -fenol
WO2012051246A1 (en) * 2010-10-12 2012-04-19 Ratiopharm Gmbh Tapentadol hydrobromide and crystalline forms thereof
EA030553B1 (ru) * 2013-01-10 2018-08-31 ФАРМА ДжРС, Д.О.О. Тапентадола малеат и его кристаллические формы
CN103553940A (zh) * 2013-11-07 2014-02-05 南京艾德凯腾生物医药有限责任公司 一种新晶型盐酸他喷他多的制备方法

Also Published As

Publication number Publication date
HRP20210503T1 (hr) 2021-10-15
ES2860907T3 (es) 2021-10-05
EP3377049A4 (en) 2019-06-12
EP3377049A1 (en) 2018-09-26
DK3377049T3 (en) 2021-04-12
EP3377049B1 (en) 2021-01-06
HUE054338T2 (hu) 2021-08-30
WO2017085734A1 (en) 2017-05-26

Similar Documents

Publication Publication Date Title
IL255738A (en) A new crystalline form of lenbatinib mesylate and a process for its preparation
HUP1400475A2 (en) Novel process for preparation of treprostinil and its salts
PT3580219T (pt) Processo para a preparação de remimazolam e formas de estado sólido de sais de remimazolam
PL3174988T3 (pl) Sposób wytwarzania kwasu mlekowego
HUE072197T2 (hu) Ozanimod és ozanimod-hidroklorid kristályos alakjai és eljárások azok elõállítására
IL248656A0 (en) A system for preparing seeds and a method for use
IL254530A0 (en) Preparation method of crystalline form a of pci-32765
SI3380554T1 (sl) Kristalne oblike per-kloro-gama-ciklodekstrinov
IL272108A (en) New crystal structures of vilanterol tripentate and processes for their preparation
DK3377049T3 (en) Crystalline forms of tapentadol salts and process for preparation thereof
SG10202101979TA (en) Crystalline forms of c21h22ci2n4o2
EP3141540A4 (en) Crystalline form of chlorogenic acid and preparation method therefor
PT3327012T (pt) Formas cristalinas de bilastina e os seus métodos de preparação
HRP20190403T1 (hr) Postupak izrade lakozamida
EP2945927A4 (en) Process for preparation of fingolimod and its salts
IL253479A0 (en) Crystalline forms of efinconazole
IL254597A0 (en) Crystalline form of ahu377, method for its preparation and use
ZA201607265B (en) A process for preparation of levothyroxine and salts thereof
IL246835A0 (en) Improved process for the preparation of trazodone and its hydrochloride salt
SI3253772T1 (sl) Postopek za pripravo diosmina
GB2565419B (en) Process for preparing novel crystalline form of mesosulfuron-methyl and use thereof
GB2559718B (en) Novel crystalline form of tribenuron-methyl, process for preparation and use thereof
HUP1500647A2 (en) Intermediate of baricitinib and process for its preparation
PT3148961T (pt) Método para preparar um sal do ácido acetilsalicílico e um aminoácido básico
ZA201708170B (en) Process for the preparation of sodium cyanide